Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Prognosis of cervical cancer

In Norway, no difference in survival has been found between squamous epithelial cancer and adenocarcinoma (8).

There is not a great difference in survival among the different types of adenocarcinomas (14). Small cell cancer with neuroendocrine differentiation is associated with poor prognosis.

Younger women have longer survival mainly due to early stage diagnosis. In stage I, the size of the tumor, depth of invasion, invasion of lymph vessels, and nodal metastasis are significant for survival. (9–10,12). Uterine invasion aggravate the prognosis (14), as does extensive lymph node metastasis including paraaortal lymph nodes (12). 

 

 

Five-year relative survival for patients with cervical cancer, in percent, according to stage and diagnosis period 1974–2013.

Source: Cancer Registry of Norway

All stages combined, survival in Norway is 78%.

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2016